Participant 1 | Participant 2 | Participant 3 | Participant 4 | Participant 5 | Participant 6 | Participant 7 | Participant 8 | |
Intervention group status | Intervention | Intervention | Waiting list | Waiting list | Intervention | Intervention | Waiting list | Waiting list |
Initial screening | ||||||||
BMI* | 28.05 | 33.46 | 33.99 | 25.22 | 29.29 | 25.28 | 24.02 | 24.05 |
IOTF classification† | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 1 |
Baseline assessment | ||||||||
K-SADS†‡ | MDD | MDD | MDD | MDD | DD-NOS | MDD | None | MDD |
BMI† | 29.79 | 34.93 | N/A | N/A | 28.66 | 25.00 | N/A | N/A |
IOTF classification† | 2 | 2 | N/A | N/A | 2 | 1 | N/A | N/A |
MFQ-SF§ | 9 | 10 | 8 | 10 | 4 | 25 | 13 | 11 |
HoNOSCA† | 15 | 16 | 8 | 11 | 6 | 16 | 8 | 12 |
CGAS2†‡ | 65 | 58 | 60 | 67 | 74 | 60 | 69 | 75 |
Second baseline for waiting list controls | ||||||||
BMI† | N/A | N/A | 37.57 | 25.94 | N/A | N/A | 23.15 | 26.78 |
IOTF classification† | N/A | N/A | 2 | 1 | N/A | N/A | 1 | 1 |
MFQ-SF§ | N/A | N/A | 9 | 7 | N/A | N/A | 5 | 14 |
HoNOSCA† | N/A | N/A | 8 | 9 | N/A | N/A | 6 | 7 |
CGAS† | N/A | N/A | 70 | 70 | N/A | N/A | 72 | 60 |
Intervention session 4 | ||||||||
BMI† | 29.71 | 35.17 | 39.25 | 26.95 | 28.85 | 24.94 | 23.73 | 26.91 |
IOTF classification† | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 1 |
MFQ-SF§ | 6 | 9 | 14 | 7 | 2 | 21 | 4 | 12 |
CGAS† | 65 | 50 | 61 | 62 | 75 | 54 | 72 | 65 |
Intervention session 8 | ||||||||
BMI† | 30.03 | 24.51 | 40.75 | 26.57 | 27.35 | – | 23.62 | 27.29 |
IOTF classification† | 2 | 2 | 2 | 1 | 2 | – | 1 | 1 |
MFQ-SF§ | 3 | 5 | 13 | 7 | 2 | – | 5 | 12 |
CGAS† | 74 | 62 | 56 | 79 | 78 | – | 74 | 62 |
Final session (endpoint) | ||||||||
BMI† | 30.31 | 35.21 | – | 26.55 | 27.95 | 24.52 | 23.23 | 27.93 |
IOTF classification† | 2 | 2 | – | 1 | 2 | 1 | 1 | 1 |
MFQ-SF§ | 0 | 3 | – | 7 | 2 | 18 | 2 | 9 |
HoNOSCA† | 3 | 5 | – | 5 | 1 | – | 6 | 10 |
CGAS† | 82 | 65 | – | 77 | 85 | 70 | 84 | 70 |
Follow-up | ||||||||
BMI† | 29.40 | 34.95 | 39.40 | 26.06 | – | 24.84 | 23.25 | 27.51 |
IOTF classification2† | 2 | 2 | 2 | 1 | – | 1 | 1 | 1 |
MFQ-SF§ | 1 | 7 | 11 | 9 | – | 23 | 5 | 7 |
‘–’ indicates missing data.
BMI adjusted for age and sex to assess overweight/obesity; IOTF (Extended IOTF) classification: 1=overweight; 2=very overweight/obese; CGAS: 51–60=some noticeable problems (problems in more than one area); 61–70=some problems (problems in one area); 71–80=doing all right (minor impairment); 81–90=doing well.
*Self-report by adolescent or assessed in private by a member of the research team.
†Assessed by a member of the research team.
‡Consensus coding by the psychiatrist and a member of the research team.
§Self-report by adolescent.
BMI, Body Mass Index; CGAS, Children’s Global Assessment Scale; DD-NOS, depressive disorder not otherwise specified; HoNOSCA, Health of the Nation Outcome Scales for Children and Adolescents; IOTF, International Obesity Task Force; K-SADS, Kiddie-Sads-Present and Lifetime Version; MDD, major depressive disorder; MFQ-SF, Mood and Feelings Questionnaire—Short Form; N/A, not applicable.